
Company valuation, historical trends, and peer comparisons.
According to Neuronetics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 236.86M. This represents a change of 30.82% compared to the average of 181.07M of the last 4 quarters.
The mean historical Enterprise Value of Neuronetics, Inc. over the last ten years is 90.35M. The current 236.86M Enterprise Value has changed 162.18% with respect to the historical average. Over the past ten years (40 quarters), STIM's Enterprise Value was at its highest in in the June 2018 quarter at 477.99M. The Enterprise Value was at its lowest in in the June 2017 quarter at 0.
Average
90.35M
Median
92.43M
Minimum
720.69K
Maximum
198.63M
Discovering the peaks and valleys of Neuronetics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 13.63%
Maximum Annual Enterprise Value = 198.63M
Minimum Annual Increase = -78.86%
Minimum Annual Enterprise Value = 720.69K
| Year | Enterprise Value | Change |
|---|---|---|
| 2025 | 147.18M | 28.81% |
| 2024 | 114.26M | 33.01% |
| 2023 | 85.91M | -44.29% |
| 2022 | 154.21M | 161.20% |
| 2021 | 59.04M | -70.28% |
| 2020 | 198.63M | 382.78% |
| 2019 | 41.14M | -58.42% |
| 2018 | 98.96M | 13.63% |
| 2017 | 720.69K | -78.86% |
The current Enterprise Value of Neuronetics, Inc. (STIM) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
115.78M
5-year avg
112.12M
10-year avg
90.35M
Neuronetics, Inc.’s Enterprise Value is greater than Prenetics Global Limited (223.73M), greater than Nyxoah S.A. (68.47M), less than Atlantic International Corp. (574.41M), less than OmniAb, Inc. (752.01M), greater than Perspective Therapeutics, Inc. (79.35M), greater than OraSure Technologies, Inc. (111.87M), greater than Profound Medical Corp. (220.70M), greater than Codexis, Inc. (165.87M), less than Sangamo Therapeutics, Inc. (0), less than Genfit S.A. (583.82M),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 223.73M | $282.10M | |
| 68.47M | $89.64M | |
| 574.41M | $68.61M | |
| 752.01M | $756.76M | |
| 79.35M | $123.88M | |
| 111.87M | $260.36M | |
| 220.70M | $248.42M | |
| 165.87M | $120.46M | |
| 0 | $30.66M | |
| 583.82M | $445.68M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Neuronetics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Neuronetics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Neuronetics, Inc.'s Enterprise Value?
What is the highest Enterprise Value for Neuronetics, Inc. (STIM)?
What is the 3-year average Enterprise Value for Neuronetics, Inc. (STIM)?
What is the 5-year average Enterprise Value for Neuronetics, Inc. (STIM)?
How does the current Enterprise Value for Neuronetics, Inc. (STIM) compare to its historical average?